Thomas J. Herzfeld Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Thomas J. Herzfeld Advisors's BMY Position: Q4 2023 in Review
Thomas J. Herzfeld Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 1,700 shares — an estimated $98.7K sold.
Thomas J. Herzfeld Advisors first reported a position in BMY in Q3 2016 and held it in 29 quarters. The position peaked at $131K in Q2 2022. 2,366 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Thomas J. Herzfeld Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Thomas J. Herzfeld Advisors sold 1,700 Bristol-Myers Squibb shares in Q4 2023, an estimated $98.7K.
- Thomas J. Herzfeld Advisors first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 29 quarters.
- Thomas J. Herzfeld Advisors's Bristol-Myers Squibb position peaked at $131K in Q2 2022.
- 2,366 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.